You are here » Home » Companies » Bafna Pharmaceuticals Ltd - Announcements

Bafna Pharmaceuticals Ltd.

BSE: 532989 Sector: Health care
NSE: BAFNAPH ISIN Code: INE878I01022
BSE 00:00 | 09 Apr 2020 Bafna Pharmaceuticals Ltd
NSE 05:30 | 01 Jan 1970 Bafna Pharmaceuticals Ltd

Outcome Of Board Meeting Held On 13Th Feb 2020

February 13, 2020, 7:45 pm | Source: BSE



1. The un-audited financial results for the Third Quarter ending 31st December 2019. Please find attached the un-audited financial results for Third Quarter ending 31st December 2019 along with the Limited Review Report obtained from the statutory auditor of the Company.
2. Re-appointment A.K.Jain & Associates Company Secretaries Chennai as Secretarial Auditor for the financial year 2019-20.
3. Increase of remuneration of Mr. Mahaveer Chand Bafna Managing Director
4. Increase of remuneration of Mr. Paras Bafna Whole-Time Director
5. Re-appointment of Mrs. Sabitha (Whole Time Director-Women Director) w.e.f 27th March 2020 for a period of three years and Increase of remuneration.
6. Increase of Remuneration of CFO.
7. Increase of Remuneration of Company Secretary.
8. Write off of investment in the Subsidiary Company Bafna Lifestyles Remedies Limited.